Cargando…

Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown

SIMPLE SUMMARY: Concerns about potential diagnostic delays due to pandemic-related disruptions were expressed early during the COVID-19 outbreak. In the present study, we investigated the impact of the Swiss COVID-19 lockdown between March and June 2020 on newly diagnosed melanomas. Our main finding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostner, Lisa, Cerminara, Sara Elisa, Pamplona, Gustavo Santo Pedro, Maul, Julia-Tatjana, Dummer, Reinhard, Ramelyte, Egle, Mangana, Johanna, Wagner, Nikolaus Benjamin, Cozzio, Antonio, Kreiter, Saskia, Kogler, Angelika, Streit, Markus, Wysocki, Anja, Zippelius, Alfred, Läubli, Heinz, Navarini, Alexander Andreas, Maul, Lara Valeska
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139530/ https://www.ncbi.nlm.nih.gov/pubmed/35625961 http://dx.doi.org/10.3390/cancers14102360

Ejemplares similares

Swiss Recommendations for Cutaneous Basal Cell Carcinoma
por: Ramelyte, Egle, et al.
Publicado: (2022)

Educational level-dependent melanoma awareness in a high-risk population in Switzerland
por: Mueller, Alina Miriam, et al.
Publicado: (2023)

Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events
por: Müller, Benjamin, et al.
Publicado: (2023)

Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients’ Perception
por: Jahn, Anna Sophie, et al.
Publicado: (2022)

Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma
por: Fröhlich, Fabienne, et al.
Publicado: (2023)

The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
por: Dummer, Reinhard, et al.
Publicado: (2023)

Acceptance of Telemedicine Compared to In-Person Consultation From the Providers' and Users’ Perspectives: Multicenter, Cross-Sectional Study in Dermatology
por: Maul, Lara Valeska, et al.
Publicado: (2023)

Immune-Related Sclerosing Cholangitis and Subsequent Pyogenic Liver Abscesses in Two Patients With Melanoma Treated by Triplet Therapy: A Case Report
por: Schön, Viola, et al.
Publicado: (2023)

Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
por: Maredia, Hasina, et al.
Publicado: (2021)

Long-term pegylated interferon-α and its potential in the treatment of melanoma
por: Dummer, Reinhard, et al.
Publicado: (2009)

The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma
por: Boerlin, Aurelio, et al.
Publicado: (2022)

A new B-Raf inhibitor combo for advanced melanoma
por: Barysch, Marjam-Jeanette, et al.
Publicado: (2018)

Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted Therapy
por: DIMITRIOU, Florentia, et al.
Publicado: (2020)

The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in Italy
por: Gualdi, Giulio, et al.
Publicado: (2021)

Treatment reality of patients with BRAF-mutant advanced/metastatic melanoma in Switzerland in the era of choice
por: Mangana, Joanna, et al.
Publicado: (2022)

How I treat metastatic melanoma
por: Dummer, Reinhard, et al.
Publicado: (2019)

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland
por: Mangana, Joanna, et al.
Publicado: (2017)

Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
por: Läubli, Heinz, et al.
Publicado: (2015)

Diffuse Cutaneous Melanosis Associated with Malignant Melanoma
por: Mangana, Joanna, et al.
Publicado: (2015)

Skin Recovery After Discontinuation of Long-Term Moisturizer Application: A Split-Face Comparison Pilot Study
por: Maul, Julia-Tatjana, et al.
Publicado: (2020)

Lung Nodules in Melanoma Patients: Morphologic Criteria to Differentiate Non-Metastatic and Metastatic Lesions
por: Stadelmann, Simone Alexandra, et al.
Publicado: (2021)

Impact of Covid-19 on the management of patients with metastatic melanoma
por: Welti, Michèle, et al.
Publicado: (2022)

Recurrent squamous cell carcinoma of the perianal skin: a case report
por: Staeger, Ramon, et al.
Publicado: (2020)

The genetic evolution of acral melanoma
por: Wang, Meng, et al.
Publicado: (2023)

Did COVID-19 lockdown delay actually worsen melanoma prognosis?()
por: Gil-Pallares, Pedro, et al.
Publicado: (2023)

Addendum: Impact of Covid-19 on the management of patients with metastatic melanoma
por: Welti, Michèle, et al.
Publicado: (2023)

The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis
por: Guillet, Carole, et al.
Publicado: (2022)

Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma
por: Lang, Claudia C. V., et al.
Publicado: (2020)

Lockdown and Children’s Well-Being: Experiences of Children in Switzerland, Canada and Estonia
por: Stoecklin, Daniel, et al.
Publicado: (2021)

Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis
por: Kraehenbuehl, Lukas, et al.
Publicado: (2023)

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
por: Ressler, Julia Maria, et al.
Publicado: (2021)

Effects of COVID-19 Lockdown on Tumour Burden of Melanoma and Cutaneous Squamous Cell Carcinoma
por: TEJERA-VAQUERIZO, Antonio, et al.
Publicado: (2021)

Long‐Term Response to Intermittent Binimetinib in Patients with NRAS‐Mutant Melanoma
por: Matter, Alexandra Valeska, et al.
Publicado: (2020)

Melanoma patients with additional primary cancers: a single-center retrospective analysis
por: Dimitriou, Florentia, et al.
Publicado: (2019)

WITHDRAWN: How Has the COVID-19 Pandemic and Lockdown Affected Breslow Thickness in Cutaneous Melanoma?
por: Sarriugarte Aldecoa-Otalora, J., et al.
Publicado: (2021)

35132 Investigating the progression of melanoma and squamous cell carcinomas before and after the COVID-19 lockdown
por: Russell, Laura, et al.
Publicado: (2022)

Eight Years of Real-Life Experience with Smoothened Inhibitors in a Swiss Tertiary Skin Referral Center
por: Grossmann, Lara E., et al.
Publicado: (2022)

What Is New in Cutaneous T Cell Lymphoma?
por: Morgenroth, Sarah, et al.
Publicado: (2023)

The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
por: Mallardo, Domenico, et al.
Publicado: (2023)

A Report of Two Cases of Solid Facial Edema in Acne
por: Kuhn-Régnier, Sarah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sqdro1h8u6hifboqb7kuire3jd